BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 9408758)

  • 21. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome.
    Zagaria A; Anelli L; Albano F; Storlazzi CT; Liso A; Roberti MG; Buquicchio C; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2004 Apr; 150(1):81-5. PubMed ID: 15041230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia.
    Van Limbergen H; Beverloo HB; van Drunen E; Janssens A; Hählen K; Poppe B; Van Roy N; Marynen P; De Paepe A; Slater R; Speleman F
    Genes Chromosomes Cancer; 2001 Mar; 30(3):274-82. PubMed ID: 11170285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biallelic alterations of both ETV6 and CDKN1B genes in a t(12;21) childhood acute lymphoblastic leukemia case.
    Wlodarska I; Baens M; Peeters P; Aerssens J; Mecucci C; Brock P; Marynen P; Van den Berghe H
    Cancer Res; 1996 Jun; 56(11):2655-61. PubMed ID: 8653712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).
    Wlodarska I; Mecucci C; Marynen P; Guo C; Franckx D; La Starza R; Aventin A; Bosly A; Martelli MF; Cassiman JJ
    Blood; 1995 May; 85(10):2848-52. PubMed ID: 7742547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression.
    Barbouti A; Johansson B; Höglund M; Mauritzson N; Strömbeck B; Nilsson PG; Tanke HJ; Hagemeijer A; Mitelman F; Fioretos T
    Genes Chromosomes Cancer; 2002 Oct; 35(2):127-37. PubMed ID: 12203776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
    Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
    Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fusion of ETV6 to GOT1 in a case with myelodysplastic syndrome and t(10;12)(q24;p13).
    Janssen H; Wlodarska I; Mecucci C; Hagemeijer A; Vandenberghe P; Marynen P; Cools J
    Haematologica; 2006 Jul; 91(7):949-51. PubMed ID: 16757412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases.
    Albano F; Specchia G; Anelli L; Zagaria A; Storlazzi CT; Buquicchio C; Roberti MG; Liso V; Rocchi M
    Genes Chromosomes Cancer; 2003 Apr; 36(4):353-60. PubMed ID: 12619159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
    von Bergh AR; van Drunen E; van Wering ER; van Zutven LJ; Hainmann I; Lönnerholm G; Meijerink JP; Pieters R; Beverloo HB
    Genes Chromosomes Cancer; 2006 Aug; 45(8):731-9. PubMed ID: 16646086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cytogenetic characterization of rearrangements involving 12p in leukemia.
    Vieira L; Marques B; Cavaleiro C; Ambrósio AP; Jorge M; Neto A; Costa JM; Júnior EC; Boavida MG
    Cancer Genet Cytogenet; 2005 Mar; 157(2):134-9. PubMed ID: 15721634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of the ETV6 gene as a consequence of a rare translocation (12;12)(p13;q13) in treatment-induced acute myeloid leukemia after breast cancer.
    Manola KN; Georgakakos VN; Margaritis D; Stavropoulou C; Panos C; Kotsianidis I; Pantelias GE; Sambani C
    Cancer Genet Cytogenet; 2008 Jan; 180(1):37-42. PubMed ID: 18068531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11.
    Buijs A; Sherr S; van Baal S; van Bezouw S; van der Plas D; Geurts van Kessel A; Riegman P; Lekanne Deprez R; Zwarthoff E; Hagemeijer A
    Oncogene; 1995 Apr; 10(8):1511-9. PubMed ID: 7731705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular genetics in chronic myeloid leukemia with variant Ph translocation].
    Wu W; Li JY; Zhu Y; Qiu HR; Pan JL; Xu W; Chen LJ; Shen YF; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):470-3. PubMed ID: 17680547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia.
    Suzuki K; Sugawara T; Kowata S; Utsugizawa T; Ito S; Murai K; Ishida Y
    Cancer Genet Cytogenet; 2004 Apr; 150(2):159-63. PubMed ID: 15066325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG; Tarpey PS; Nacheva EP
    Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1.
    Wu HK; Heng HH; Siderovski DP; Dong WF; Okuno Y; Shi XM; Tsui LC; Minden MD
    Oncogene; 1996 Mar; 12(6):1205-12. PubMed ID: 8649822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for deletion of 9q as a two-step process in chronic myeloid leukemia.
    Rudduck-Sivaswaren C; Tien SL; Lim P; Lim E; Lie DK; Tan PH; Lee AS
    Clin Genet; 2005 Nov; 68(5):461-5. PubMed ID: 16207215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes.
    Raynaud SD; Baens M; Grosgeorge J; Rodgers K; Reid CD; Dainton M; Dyer M; Fuzibet JG; Gratecos N; Taillan B; Ayraud N; Marynen P
    Blood; 1996 Jul; 88(2):682-9. PubMed ID: 8695816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
    Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further evidence of the involvement of the c-abl oncogene in chronic myelogenous leukemia and acute lymphocytic leukemia.
    Szabo P; Macera MJ; Verma RS
    Mol Biol Med; 1988 Dec; 5(3):139-44. PubMed ID: 3072467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.